| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/2004 | WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083192A1 Polymorphis of valsartan |
| 09/30/2004 | WO2004083191A1 Novel crystalline forms of lamotrigine |
| 09/30/2004 | WO2004083190A1 Biaryl substituted triazoles as sodium channel blockers |
| 09/30/2004 | WO2004083189A1 Biaryl substituted triazoles as sodium channel blockers |
| 09/30/2004 | WO2004083188A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/30/2004 | WO2004083186A1 Therapeutic agent for viral hepatitis and carcinostatic agent |
| 09/30/2004 | WO2004083185A2 Phenyl substituted imidazole derivatives |
| 09/30/2004 | WO2004083184A1 Receptor antagonist |
| 09/30/2004 | WO2004083183A1 Novel crystalline forms of aripiprazole |
| 09/30/2004 | WO2004083179A1 Remedy for diabetes |
| 09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 09/30/2004 | WO2004083173A2 Ketopiperazine derivatives as bradykinin antagonists |
| 09/30/2004 | WO2004083172A2 Process for the preparation of 7-amino (p-hydroxyphenylglyclyamido) cephem compounds |
| 09/30/2004 | WO2004083171A2 Use of pyridin-2-ylmethylamine derivatives for the treatment of chronic neuropathological or psychogenic pain symptoms |
| 09/30/2004 | WO2004083165A1 Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides |
| 09/30/2004 | WO2004083155A2 Nucleotide lipid ester derivatives |
| 09/30/2004 | WO2004082822A2 Methods for isolating crystalline form i of 5-azacytidine |
| 09/30/2004 | WO2004082720A1 Drug for treating hemophilia and method of treating hemophilia using the same |
| 09/30/2004 | WO2004082718A1 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 09/30/2004 | WO2004082717A1 Percutaneously absorbable anesthetic |
| 09/30/2004 | WO2004082716A1 PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA |
| 09/30/2004 | WO2004082715A1 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 09/30/2004 | WO2004082704A1 Method of treating inflammtory disease associated with bone destruction |
| 09/30/2004 | WO2004082702A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 09/30/2004 | WO2004082699A2 Use of incense or hydrogenation products for preventing and/or treating a cerebral ischemia and/or cerebral traumatic lesion |
| 09/30/2004 | WO2004082698A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 09/30/2004 | WO2004082697A1 Compositions of natural products and use thereof |
| 09/30/2004 | WO2004082696A1 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 09/30/2004 | WO2004082693A1 Composition for administration of iron for the treatment of restless legs syndrome |
| 09/30/2004 | WO2004082691A1 Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 for immune activation or prevention and treatment of cancer and the preparation method thereof |
| 09/30/2004 | WO2004082690A1 Regulation of cell surface proteins |
| 09/30/2004 | WO2004082689A1 Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor |
| 09/30/2004 | WO2004082688A1 Phosphatidylglycerol (pg) receptor agonists and antagonists |
| 09/30/2004 | WO2004082686A2 Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction |
| 09/30/2004 | WO2004082685A1 Process for the preparation of donepezil and derivatives thereof |
| 09/30/2004 | WO2004082684A1 Stable oral formulations of aminopyridines and uses thereof |
| 09/30/2004 | WO2004082683A1 Therapeutic and/or preventive agent for chronic skin disease |
| 09/30/2004 | WO2004082681A1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases |
| 09/30/2004 | WO2004082680A1 Pramipexole for reducing excessive food intake by children |
| 09/30/2004 | WO2004082679A1 Release control compositions |
| 09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | WO2004082676A1 Drug formulations having long and medium chain triglycerides |
| 09/30/2004 | WO2004082675A1 Method for increasing the oral bioavailability of s-[2- ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanethioate |
| 09/30/2004 | WO2004082674A1 Carnitine retention |
| 09/30/2004 | WO2004082673A1 Liquid ophthalmic composition |
| 09/30/2004 | WO2004082672A1 Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 09/30/2004 | WO2004082671A1 Anti-microbially active diamine-based guanine derivatives |
| 09/30/2004 | WO2004082670A1 Methadone-containing compositions for parenteral administration and use thereof |
| 09/30/2004 | WO2004082669A2 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders |
| 09/30/2004 | WO2004082668A1 Coenzyme q10-containing proliposome and preparation thereof |
| 09/30/2004 | WO2004082667A1 Treatment of type 1 diabetes with pde5 inhibitors |
| 09/30/2004 | WO2004082664A1 Water-soluble tablets of metformin |
| 09/30/2004 | WO2004082659A1 Method for preparing small particles |
| 09/30/2004 | WO2004082648A1 Composition comprising particulate zinc materials having a defined crystallite size |
| 09/30/2004 | WO2004082638A2 Histone deacetylase inhibitors |
| 09/30/2004 | WO2004082637A2 Combination of an aldosterone receptor antagonist and an endothelin receptor antagonist and/or endothelin converting enzyme inhibitor |
| 09/30/2004 | WO2004082636A2 Combination of an aldosterone receptor antagonist and a neutral endopeptidase inhibitor |
| 09/30/2004 | WO2004082634A2 Facially amphiphilic polymers and oligomers and uses thereof |
| 09/30/2004 | WO2004082631A2 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D2 |
| 09/30/2004 | WO2004082630A2 High potency dopaminergic treatment of neurological impairment associated with brain injury |
| 09/30/2004 | WO2004082628A2 Improved bioavailability and improved delivery of acidic pharmaceutical drugs |
| 09/30/2004 | WO2004082624A2 Modafinil-based neurorehabilitation of impaired neurological function associated with injury |
| 09/30/2004 | WO2004082622A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 09/30/2004 | WO2004082621A2 Novel ppar agonists, pharmaceutical compositions and uses thereof |
| 09/30/2004 | WO2004082620A2 Oxycodone conjugates with lower the abuse potential and extended duration of action |
| 09/30/2004 | WO2004082619A2 Forms of 5-azacytidine |
| 09/30/2004 | WO2004082618A2 Synthesis of 5-azacytidine |
| 09/30/2004 | WO2004082613A2 2,4-diamino-5-[5’-substituted-benzyl] pyrimidines and 2,4-diamino-6-[5’-substituted-benzyl] quinazolines |
| 09/30/2004 | WO2004082612A2 Liposomal formulations and methods of use |
| 09/30/2004 | WO2004082609A2 Composition and method for appetite and carving suppression and mood enhancement |
| 09/30/2004 | WO2004082606A2 Fused pyrrole compounds |
| 09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004082601A2 Method of treating diabetes and diabetes-related disorders |
| 09/30/2004 | WO2004082600A2 Method and system for administering a drug |
| 09/30/2004 | WO2004082599A2 Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| 09/30/2004 | WO2004082593A2 Pharmaceutical compositions of cetp inhibitors |
| 09/30/2004 | WO2004082591A2 Pharmaceutical composition for treatment of diabetes mellitus |
| 09/30/2004 | WO2004082590A2 A low dose corticosteroid composition |
| 09/30/2004 | WO2004082589A2 Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| 09/30/2004 | WO2004082588A2 Dispersible formulation of an anti-inflammatory agent |
| 09/30/2004 | WO2004082587A2 Stable lamotrigine pharmaceutical compositions and processes for their preparation |
| 09/30/2004 | WO2004082586A2 Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
| 09/30/2004 | WO2004082584A2 5ht2c receptor antagonists in the treatment of schizophrenia |
| 09/30/2004 | WO2004082583A2 Use of oligogalacturonides in cosmetics or for the preparation of a dermatological or pharmaceutical composition |
| 09/30/2004 | WO2004082582A2 Use of diazoxide in the treatment of ischemia retinae |
| 09/30/2004 | WO2004082581A2 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 09/30/2004 | WO2004082580A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 09/30/2004 | WO2004082579A2 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 09/30/2004 | WO2004082577A2 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/30/2004 | WO2004082463A2 Folate receptor gene modulation for cancer diagnosis and therapy |
| 09/30/2004 | WO2004082454A2 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative |
| 09/30/2004 | WO2004075892A3 Combination therapy for hypertension using lercanidipine and an angiotensin ii receptor blocker |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004073603A3 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/30/2004 | WO2004065578A3 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 09/30/2004 | WO2004064820A3 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels |
| 09/30/2004 | WO2004064785A9 Cancer therapy sensitizer |
| 09/30/2004 | WO2004063348A8 Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators |
| 09/30/2004 | WO2004062659A8 Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy |